Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000569926 | SCV000675420 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001697389 | SCV000719540 | likely benign | not provided | 2018-06-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000870087 | SCV001011562 | likely benign | Tuberous sclerosis 1 | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000870087 | SCV002040415 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506385 | SCV002811955 | likely benign | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2021-09-30 | criteria provided, single submitter | clinical testing |